16 studies found for:    IL12B
Show Display Options
Rank Status Study
1 Completed
Has Results
A Study of the Safety and Efficacy of Ustekinumab (CNTO 1275) in Participants With Crohn's Disease
Condition: Crohn Disease
Interventions: Drug: Ustekinumab 90 mg;   Drug: Ustekinumab 4.5 mg/kg;   Drug: Placebo SC;   Drug: Placebo IV
2 Recruiting Efficacy, Safety and Pharmacokinetics of BI 655066 in Patients With Active, Moderate-to-severe Crohn's Disease.
Condition: Crohn Disease
Interventions: Drug: BI 655066 (high dose);   Drug: BI 655066 (low dose);   Drug: BI 655066 one dose;   Drug: placebo dose
3 Recruiting Pilot Study of Ustekinumab for Subjects With Chronic Atopic Dermatitis
Condition: Atopic Dermatitis
Interventions: Drug: Ustekinumab;   Other: Placebo
4 Not yet recruiting IL-23/IL-12 Imbalance and T Lymphocyte Polarization in HIV Infection
Condition: HIV Reservoirs
Intervention: Other: Blood sample and recto-colic biopsies
5 Unknown  Immunotherapy After Surgery in Treating Patients With Breast Cancer, Colon Cancer, or Melanoma
Conditions: Breast Cancer;   Colorectal Cancer;   Melanoma (Skin)
Interventions: Biological: Corynebacterium granulosum P40;   Procedure: adjuvant therapy
6 Completed
Has Results
A Study of the Safety and Effectiveness of Ustekinumab in Patients With Psoriatic Arthritis
Condition: Arthritis, Psoriatic
Interventions: Drug: Placebo;   Drug: Ustekinumab 45 mg;   Drug: Ustekinumab 90 mg
7 Completed
Has Results
A Safety and Efficacy Study of CNTO1275 in Patients With Multiple Sclerosis
Condition: Multiple Sclerosis
Intervention: Drug: CNTO 1275
8 Completed
Has Results
A Study of the Safety and Efficacy of Ustekinumab in Patients With Psoriatic Arthritis With and Without Prior Exposure to Anti-TNF Agents
Condition: Arthritis, Psoriatic
Interventions: Drug: placebo;   Drug: ustekinumab 45 mg;   Drug: ustekinumab 90 mg
9 Completed
Has Results
Safety and Efficacy of the Addition of 0.3% Lidocaine With EVOLENCE®
Conditions: Aging;   Pain
Interventions: Device: Evolence;   Device: Lidocaine;   Drug: topical anesthetic
10 Completed
Has Results
A Phase II, Dose Ranging Study Of CP-690,550 Eye Drops In Patients With Dry Eye Disease
Condition: Dry Eye Syndromes
Interventions: Drug: CP-690,550 Eye drops;   Drug: CP-690,550 Eye drops-vehicle;   Drug: Sodium Hyaluronate
11 Completed Exhaled Nitric Oxide and Airway Caliber in Children With Asthma
Condition: Asthma in Children
12 Unknown  Maternal Serum Cytokine Levels and Angiogenic Factor Levels in IVF vs Spontaneously Conceived Pregnancies
Condition: Infertility
13 Completed Effect of Single Oral Dose BIRB 796 BS on Endotoxin-induced Inflammatory Responses in Healthy Human Subjects
Condition: Healthy
Interventions: Drug: BIBR 796 BS, low dose;   Drug: BIBR 796 BS, high dose;   Drug: Placebo;   Drug: Lipopolysaccharide
14 Recruiting European Stop Tyrosine Kinase Inhibitor Study
Condition: Chronic Myeloid Leukemia
Intervention: Other: Stopping treatment with TKI
15 Completed Rituximab for Pulmonary Sarcoidosis
Condition: Sarcoidosis
Intervention: Drug: Rituximab
16 Completed Intensity Modulated Radiotherapy in Recurrent T1-2 Nasopharyngeal Carcinoma
Condition: Nasopharyngeal Cancer Recurrent
Intervention: Radiation: 3D-CRT, IMRT, BT, BT combined 3D-CRT or IMRT

Indicates status has not been verified in more than two years